Pharma 2020 Essay

13189 Words Mar 15th, 2014 53 Pages
www.pwc.com/pharma2020

Pharma 2020: Supplying the future Which path will you take?
Pharmaceuticals and Life Sciences

Previous publications in this series include:

Pharmaceuticals

Pharma 2020: The vision Which path will you take?*

Published in June 2007, this paper highlights a number of issues that will have a major bearing on the industry by 2020. The publication outlines the changes we believe will best help pharmaceutical companies realise the potential the future holds to enhance the value they provide to shareholders and society alike.

Pharmaceuticals and Life Sciences

Pharma 2020: Challenging business models Which path will you take?

Fourth in the Pharma 2020 series and published in April 2009, this report highlights how
…show more content…
These changes will enable the industry to market and sell its products more cost-effectively, to create new opportunities and to generate greater customer loyalty across the healthcare spectrum.

The fifth report in our series, published in December 2009, focuses on the opportunities and challenges from a tax perspective. It discusses how the political, economic, scientific and social trends currently shaping the commercial environment, together with the development of new, more collaborative business models, will exert increasing pressure on effective tax rates within the industry. It also shows how companies can adapt their tax strategies to support the provision of outcomesbased healthcare and remain competitive.

All these publications are available to download at: www.pwc.com/pharma2020

Table of contents
Introduction The times they are a-changin’
• New product types • Live licensing • The increasing emphasis on outcomes • New modes of healthcare delivery • The growing importance of the emerging markets • Greater public scrutiny • Environmental pressures • The collective impact of these trends

2 3

Removing the roadblocks
• New development technologies • New manufacturing technologies • New distribution technologies • New patient interface technologies • Greater collaboration

10

Choosing among the options
• The virtual manufacturer • The service innovator • The low-cost provider • The

Related Documents